Brown P H, Krishnamurthy G T, Bobba V V, Kingston E
J Nucl Med. 1981 Feb;22(2):177-83.
Radiation dose from Tc-99m HIDA has been calculated for normal subjects and for patients with various hepatobiliary diseases classified into four groups based on serum bilirubin level. The calculation was performed on biokinetic radioactivity data from blood, urine, liver, gallbladder, and intestines, using a biological approach that included a catenary model of the digestive organs. For normal subjects the critical organs were the gallbladder and the upper and lower large intestine, with doses of 910, 300, 200 mrad/mCi, respectively. The bone marrow, ovaries, and testes received 24, 62, and 4 mrad/mCi. For Group 4 patients with severe hepatobiliary disease (bilirubin greater than 10 mg/dl), the critical organs were the kidney, urinary bladder, and gallbladder, with doses of 130, 110, and 100 mrad/mCi. The bone marrow, ovaries, and testes received 9, 13, and 6 mrad/mCi. Thus the critical organs and overall radiation doses to organs change between health and disease.
已针对正常受试者以及根据血清胆红素水平分为四组的各种肝胆疾病患者计算了Tc-99m HIDA的辐射剂量。该计算是根据来自血液、尿液、肝脏、胆囊和肠道的生物动力学放射性数据进行的,采用了一种包含消化器官悬链线模型的生物学方法。对于正常受试者,关键器官是胆囊以及大肠上段和下段,剂量分别为910、300、200毫拉德/毫居里。骨髓、卵巢和睾丸接受的剂量分别为24、62和4毫拉德/毫居里。对于患有严重肝胆疾病(胆红素大于10毫克/分升)的第4组患者,关键器官是肾脏、膀胱和胆囊,剂量分别为130、110和100毫拉德/毫居里。骨髓、卵巢和睾丸接受的剂量分别为9、13和6毫拉德/毫居里。因此,健康与疾病状态下关键器官以及器官的总体辐射剂量会发生变化。